Skip to content
lsd.com
CompletedPhase 1Results posted

Mood Effects of Serotonin Agonists Extended

NCT03934710 · MESA-E · University of Chicago

Closed to entry
Status
Not accepting participants
Phase 1
Phase
56
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • DASS-21

    Measured over End of session 5, approximately 2 weeks from baseline

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 40 Years
Ages
All
Sex
Accepted
Healthy volunteers
Inclusion Criteria: * English fluency * High school level education * BMI between 19 and 30 Exclusion Criteria: * Diagnosed medical condition * women who are nursing, pregnant, or plan to become pregnant within 3 months * History of psychotic disorder or family history of psychotic disorder

Where

1 study site

FacilityCityRegionCountry
Matthew BonaChicagoIllinoisUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT03934710 on ClinicalTrials.gov →

Last updated in the registry 2023-11-29. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance

Recruiting in

All 12 trials from University of Chicago →